Episode Details

Back to Episodes
19%功能性治愈!治愈乙肝的曙光来了!

19%功能性治愈!治愈乙肝的曙光来了!

Episode 1 Published 4 weeks, 1 day ago
Description

GSK近日公布,其在研反义寡核苷酸药物bepirovirsen治疗慢性乙型肝炎的两项关键3期临床试验取得突破性阳性结果。数据同步发表于《新英格兰医学杂志》,并在欧洲肝脏研究学会年会上公布,有望改写全球慢乙肝治疗格局。




Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us